Obtaining information on intra-fraction prostate displacement in radiotherapy determined from pre- and post-treatment kV imaging.

Autor: Kron, T., Thomas, J., Fox, C., Thompson, A., Owen, R., Herschtal, A., Haworth, A., Tai, KH., Foroudi, F.

Publikováno v: World Congress on Medical Physics & Biomedical Engineering, September 7 - 12, 2009, Munich, Germany; 2009, p535-538, 4p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.

Autor: D'Amico AV, Denham JW, Crook J, Chen MH, Goldhaber SZ, Lamb DS, Joseph D, Tai KH, Malone S, Ludgate C, Steigler A, Kantoff PW

Publikováno v: Journal of Clinical Oncology; 6/10/2007, Vol. 25 Issue 17, p2420-2425, 6p

The TROG 15.01 stereotactic prostate adaptive radiotherapy utilizing kilovoltage intrafraction monitoring (SPARK) clinical trial database.

Autor: Sengupta C; Image X Institute, The University of Syndey, Sydney, Australia., Nguyen DT; Image X Institute, The University of Syndey, Sydney, Australia., Li Y; Image X Institute, The University of Syndey, Sydney, Australia., Hewson E; Image X Institute, The University of Syndey, Sydney, Australia., Ball H; Image X Institute, The University of Syndey, Sydney, Australia., O'Brien R; Image X Institute, The University of Syndey, Sydney, Australia.; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia., Booth J; Norther Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Kipritidis J; Norther Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Eade T; Norther Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Kneebone A; Norther Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Hruby G; Norther Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Bromley R; Norther Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia., Greer P; Department of Radiation Oncology, Calvary Mater Newcastle, Newcastle, Australia., Martin J; Department of Radiation Oncology, Calvary Mater Newcastle, Newcastle, Australia., Hunter P; Department of Radiation Oncology, Calvary Mater Newcastle, Newcastle, Australia., Wilton L; Department of Radiation Oncology, Calvary Mater Newcastle, Newcastle, Australia., Moodie T; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia., Hayden A; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia., Turner S; Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia., Hardcastle N; Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia., Siva S; Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia., Tai KH; Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia., Arumugam S; Liverpool and Macarthur Cancer Therapy Centres, Liverpool Hospital, Liverpool, Australia., Sidhom M; Liverpool and Macarthur Cancer Therapy Centres, Liverpool Hospital, Liverpool, Australia., Poulsen P; Department of Oncology, Aarhus University Hospital and Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia., Moore A; TROG Cancer Research, Waratah, Australia., Keall P; Image X Institute, The University of Syndey, Sydney, Australia.

Publikováno v: Medical physics [Med Phys] 2024 Nov 23. Date of Electronic Publication: 2024 Nov 23.